Cellulose Formate‐Based Surgical Sutures With Tunable Absorbability and Enhanced Biocompatibility

Why It Matters

The breakthrough offers a fully absorbable, renewable suture that matches or exceeds the performance of current collagen sutures while reducing infection risk, addressing a key limitation of traditional cellulose sutures. Its tunable degradation aligns with tissue healing timelines, potentially improving surgical outcomes and lowering postoperative complications.

Key Takeaways

• Cellulose formate thread combined with collagen achieves surgical strength
• Tunable absorbability achieved by adjusting polymerization and substitution degrees
• Degradation converts 11.6% cellulose to glucose in 56 days
• Thread exhibits superior antibacterial activity versus standard collagen sutures
• Minimal inflammation and faster wound healing observed in animal models

Pulse Analysis

Absorbable sutures are a cornerstone of modern surgery, yet many rely on animal‑derived collagen or synthetic polymers that raise concerns about biocompatibility, supply chain stability, and environmental impact. Traditional cellulose sutures, while renewable, have been non‑absorbable because human tissues lack cellulase enzymes to break them down. The new cellulose formate (CF) thread bridges this gap by integrating collagen at a 1:1 weight ratio and applying a poly(vinyl alcohol) coating, delivering tensile strength and toughness on par with existing commercial sutures while retaining the sustainability of plant‑based materials.

The innovation lies in its tunable degradation profile. By varying the polymerization degree and substitution degree of the CF polymer, manufacturers can program the suture to lose more than half of its mechanical strength within 21 to 49 days, matching the typical healing window for internal tissues. During physiological breakdown, a modest release of formic acid catalyzes the conversion of approximately 11.6 % of the CF into glucose over 56 days, allowing the body to metabolize the by‑products safely. In addition, the CF‑collagen composite exhibits intrinsic antibacterial activity that surpasses conventional collagen sutures, reducing the risk of post‑operative infections without the need for added antimicrobial agents.

From a market perspective, this green suture offers a compelling value proposition. Hospitals seeking to lower infection rates and adopt more sustainable medical supplies can benefit from a product that combines renewable feedstocks, customizable absorbability, and proven biocompatibility. Regulatory pathways may be streamlined given the use of well‑characterized materials like cellulose, collagen, and PVA, potentially accelerating time‑to‑market. As surgical teams prioritize patient outcomes and environmental stewardship, cellulose formate‑based sutures could become a new standard for absorbable wound closure across a broad range of procedures.